CBER Biologics Effectiveness and Safety (BEST): Initiative Community Engagement and Development Initiative

Closed Solicitation Posted Aug 13, 2020

This opportunity was awarded. See the award notice from Sep 30, 2020.

Solicitation number: FDA-20-223-SOL-1224066
Agency: FDA Office of Acquisition and Grant Services Food and Drug Administration, Department of Health and Human Services
Responses due: Sep 11, 2020, 2:00 PM ET
Set-aside: No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated Sep 30, 2020.

See Attached Solicitation Files

File	Type	Posted
Attachment B - Task Order 1 SOW.pdf	PDF	Aug 13, 2020
Attachment H - Sample Commitment Letter.pdf	PDF	Aug 13, 2020
SF33 FDA-SOL-1224066.pdf	PDF	Aug 13, 2020
Attachment F - Past Performance Questionnaire.pdf	PDF	Aug 13, 2020
Attachment I - HHS Subcontracting Plan.doc	DOC document	Aug 13, 2020
Attachment G - Sample Client Letter for Past Performance.pdf	PDF	Aug 13, 2020
Attachment E - Task Order Mapping Matrix.xls	XLS spreadsheet	Aug 13, 2020
Attachment A - IDIQ SOW.pdf	PDF	Aug 13, 2020
Attachment C - Form 3398 Access to Non-Public Info.pdf	PDF	Aug 13, 2020
Attachment D - WD_15-4281 (Rev.-16).pdf	PDF	Aug 13, 2020
FDA-20-223-SOL-1224066 Section B.pdf	PDF	Aug 13, 2020

Show all 11

Notice	Type	Posted
CBER Biologics Effectiveness and Safety (BEST): Initiative Community Engagement and Development Initiative Award	Award Notice	Sep 30, 2020
This notice Latest solicitation	Solicitation	Aug 13, 2020
CBER Biologics Effectiveness and Safety (BEST): Initiative Community Engagement and Development Initiative Original	Pre-Solicitation	Aug 13, 2020

On GovTribe

Try for free Login